Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sevoflurane added to TIVA on MEP stimulus intensity and threshold
jRCT1011240024Not yet recruiting
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sevoflurane and propofol in brain neoplasm. Primary endpoint: Suprathreshold stimulus intensity under different anesthetic conditions. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
sevofluranepropofol
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on jRCT1011240024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011240024.